Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor
- Autores
- Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.
- Año de publicación
- 2001
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state.
Fil: Arias, Hugo Rubén. Texas Tech University. Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Mccardy, Elizabeth A.. Texas Tech University. Health Sciences Center; Estados Unidos
Fil: Blanton, Michael P.. Texas Tech University. Health Sciences Center; Estados Unidos - Materia
-
Nicotinic Acetylcholine Receptor
Dizoclipine
Photoaffinity Labeling
Radioligand Binding - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/78744
Ver los metadatos del registro completo
id |
CONICETDig_f4aa92b7bf1cce78f03840f88d282f22 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/78744 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptorArias, Hugo RubénMccardy, Elizabeth A.Blanton, Michael P.Nicotinic Acetylcholine ReceptorDizoclipinePhotoaffinity LabelingRadioligand Bindinghttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state.Fil: Arias, Hugo Rubén. Texas Tech University. Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Mccardy, Elizabeth A.. Texas Tech University. Health Sciences Center; Estados UnidosFil: Blanton, Michael P.. Texas Tech University. Health Sciences Center; Estados UnidosAmerican Society for Pharmacology and Experimental Therapeutics2001-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/78744Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.; Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 59; 5; 5-2001; 1051-10600026-895X1521-0111CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://molpharm.aspetjournals.org/content/59/5/1051info:eu-repo/semantics/altIdentifier/doi/10.1124/mol.59.5.1051info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:02:12Zoai:ri.conicet.gov.ar:11336/78744instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:02:12.46CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
title |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
spellingShingle |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor Arias, Hugo Rubén Nicotinic Acetylcholine Receptor Dizoclipine Photoaffinity Labeling Radioligand Binding |
title_short |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
title_full |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
title_fullStr |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
title_full_unstemmed |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
title_sort |
Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor |
dc.creator.none.fl_str_mv |
Arias, Hugo Rubén Mccardy, Elizabeth A. Blanton, Michael P. |
author |
Arias, Hugo Rubén |
author_facet |
Arias, Hugo Rubén Mccardy, Elizabeth A. Blanton, Michael P. |
author_role |
author |
author2 |
Mccardy, Elizabeth A. Blanton, Michael P. |
author2_role |
author author |
dc.subject.none.fl_str_mv |
Nicotinic Acetylcholine Receptor Dizoclipine Photoaffinity Labeling Radioligand Binding |
topic |
Nicotinic Acetylcholine Receptor Dizoclipine Photoaffinity Labeling Radioligand Binding |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.1 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state. Fil: Arias, Hugo Rubén. Texas Tech University. Health Sciences Center; Estados Unidos. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Mccardy, Elizabeth A.. Texas Tech University. Health Sciences Center; Estados Unidos Fil: Blanton, Michael P.. Texas Tech University. Health Sciences Center; Estados Unidos |
description |
Although the dissociative anesthetic dizocilpine [(+)-MK-801] inhibits nicotinic acetylcholine receptor (AChR) function in a noncompetitive manner, the location of the dizocilpine binding site(s) has yet to be clearly established. Thus, to characterize the binding site for dizocilpine on the AChR we examined 1) the dissociation constant (Kd) and stoichiometry of [3H]dizocilpine binding; 2) the displacement of dizocilpine radioligand binding by noncompetitive inhibitors (NCIs) and conversely dizocilpine displacement of fluorescent and radiolabeled NCIs from their respective high-affinity binding sites on the AChR; and 3) photoaffinity labeling of the AChR using 125I-dizocilpine. The results establish that one high-affinity (Kd = 4.8 μM) and several (3-6) low-affinity (Kd = ∼ 140 μM) binding sites exist for dizocilpine on the desensitized and resting AChR, respectively. The binding of the fluorescent NCIs ethidium, quinacrine, and crystal violet as well as [3H]thienylcyclohexylpiperidine was inhibited by dizocilpine on desensitized AChRs. However, Schild-type analyses indicate that only the inhibition of quinacrine in the desensitized state seems to be mediated by a mutually exclusive action. Photoaffinity labeling of the AChR by 125I-dizocilpine was primarily restricted to the α1 subunit and subsequent mapping revealed that the principal sites of labeling are localized to the M4 (∼70%) and M1 (30%) transmembrane domains. Collectively, the data indicate that the high-affinity dizocilpine binding site is not located in the lumen of the ion channel but probably near the quinacrine binding locus at a nonluminal domain in the AChR desensitized state. |
publishDate |
2001 |
dc.date.none.fl_str_mv |
2001-05 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/78744 Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.; Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 59; 5; 5-2001; 1051-1060 0026-895X 1521-0111 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/78744 |
identifier_str_mv |
Arias, Hugo Rubén; Mccardy, Elizabeth A.; Blanton, Michael P.; Characterization of the dizocilpine binding site on the nicotinic acetylcholine receptor; American Society for Pharmacology and Experimental Therapeutics; Molecular Pharmacology; 59; 5; 5-2001; 1051-1060 0026-895X 1521-0111 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://molpharm.aspetjournals.org/content/59/5/1051 info:eu-repo/semantics/altIdentifier/doi/10.1124/mol.59.5.1051 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
American Society for Pharmacology and Experimental Therapeutics |
publisher.none.fl_str_mv |
American Society for Pharmacology and Experimental Therapeutics |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842980001097449472 |
score |
13.004268 |